The Irish National Adverse Event Study 2 (INAES 2): longitudinal trends in adverse event rates in the Irish healthcare system BMJ Quality & Safety Adverse Event Reporting in Clinical Trials From toxicity assessment to adaptive safety care: implementing comprehensive fast track safety evaluation for anticancer drug development ESMO Open Clinical spectrum and evolution of immune checkpoint inhibitors toxicities over a decadea worldwide perspective eClinicalMedicine Disproportionality analysis of adverse events associated with ipilimumab and nivolumab combination therapy based on FAERS database Scientific Reports